• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T1、2期声门癌的超分割加速放疗。时间剂量因素的考量。

Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.

作者信息

Sakata Koh-ichi, Someya Masanori, Hori Masakazu, Nakata Kensei, Takagi Masaru, Hareyama Masato

机构信息

Department of Radiology, Sapporo Medical University, School of Medicine, S1W16, Chuo-Ku, Sapporo, 060-8543, Japan.

出版信息

Strahlenther Onkol. 2008 Jul;184(7):364-9. doi: 10.1007/s00066-008-1819-1. Epub 2008 Oct 1.

DOI:10.1007/s00066-008-1819-1
PMID:19016035
Abstract

BACKGROUND AND PURPOSE

Hyperfractionated accelerated radiotherapy without a split (AF) has been performed to improve the local control probability of early glottic carcinomas since 1990 in the authors' institution. Here, they report their experience treating early glottic cancer patients with AF in a single institution who have a long follow-up period.

PATIENTS AND METHODS

131 T1 N0 M0 glottic cancers and 65 T2 N0 M0 glottic cancers were treated with conventional fractionation (CF) from 1984 to 1989 and with AF since 1990. CF consisted of five daily fractions of 2 Gy per week, to a total dose of 64 Gy. AF consisted of 1.72 Gy per fraction, two fractions per day, 5 days a week, to a total dose of 55 or 58.5 Gy.

RESULTS

The 5-year local control probability for T1 tumors was 94% with 58.5 Gy and 87% with 55 Gy of AF, whereas it amounted to 80% with CF. For T2 tumors, it was 56% with 58.5 Gy and 68% with 55 Gy of AF, whereas it amounted to 64% with CF. The data of T2 should be evaluated with caution due to the small number of patients. Patients with AF had more severe mucosal reactions but no severe late reactions.

CONCLUSION

AF significantly improved the local control rates for T1 glottic cancer.

摘要

背景与目的

自1990年起,作者所在机构开展了不分次的超分割加速放疗(AF),以提高早期声门癌的局部控制率。在此,他们报告在单一机构对早期声门癌患者进行AF治疗且随访期较长的经验。

患者与方法

1984年至1989年,131例T1 N0 M0声门癌和65例T2 N0 M0声门癌采用常规分割放疗(CF),自1990年起采用AF。CF为每周5次,每次2 Gy,总剂量64 Gy。AF为每次1.72 Gy,每天2次,每周5天,总剂量55或58.5 Gy。

结果

T1肿瘤采用58.5 Gy的AF时5年局部控制率为94%,采用55 Gy时为87%,而CF为80%。对于T2肿瘤,采用58.5 Gy的AF时为56%,采用55 Gy时为68%,而CF为64%。由于患者数量较少,T2的数据应谨慎评估。接受AF治疗的患者黏膜反应更严重,但无严重晚期反应。

结论

AF显著提高了T1声门癌的局部控制率。

相似文献

1
Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.T1、2期声门癌的超分割加速放疗。时间剂量因素的考量。
Strahlenther Onkol. 2008 Jul;184(7):364-9. doi: 10.1007/s00066-008-1819-1. Epub 2008 Oct 1.
2
A randomised trial of accelerated radiotherapy for localised invasive bladder cancer.局部浸润性膀胱癌加速放疗的随机试验。
Radiother Oncol. 2005 Apr;75(1):34-43. doi: 10.1016/j.radonc.2004.11.003. Epub 2004 Nov 25.
3
Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy.常规分割放疗治疗早期声门癌和声门上癌的比较
Strahlenther Onkol. 1993 Oct;169(10):584-9.
4
Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.T1a和T1bN0M0期声门癌放疗的长期结果
Laryngoscope. 2008 Aug;118(8):1417-21. doi: 10.1097/MLG.0b013e3181781791.
5
Accelerated radiotherapy for T1, 2 glottic carcinoma: analysis of results with KI-67 index.T1、2期声门癌的加速放疗:基于KI-67指数的结果分析
Int J Radiat Oncol Biol Phys. 2000 Apr 1;47(1):81-8. doi: 10.1016/s0360-3016(00)00409-0.
6
Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.早期声门癌伴前联合受累单纯放疗后局部控制率降低。
Strahlenther Onkol. 2004 Feb;180(2):84-90. doi: 10.1007/s00066-004-1164-y.
7
Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3.为何要在第3周开始对晚期喉癌进行加速放疗中的同步增敏治疗?
Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):62-9. doi: 10.1016/j.ijrobp.2004.09.007.
8
Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.早期声门癌患者的放射治疗:一组连续入选的未筛选患者的单因素和多因素分析
Cancer. 2003 Aug 15;98(4):765-72. doi: 10.1002/cncr.11575.
9
Overall time in telecobalt therapy for T1 glottic carcinoma treated with 2 Gy per day.T1期声门癌采用每天2Gy剂量进行远距离钴治疗的总时间。
Strahlenther Onkol. 1995 Aug;171(8):475-7.
10
Conservative treatment of early glottic carcinomas with exclusive radiotherapy.早期声门癌单纯放射治疗的保守治疗
Cancer Radiother. 2004 Oct;8(5):288-96. doi: 10.1016/j.canrad.2004.08.003.

引用本文的文献

1
Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer-A Multicenter Study.I-II期声门型喉癌放疗疗效的影响因素——一项多中心研究
Front Oncol. 2019 Sep 20;9:932. doi: 10.3389/fonc.2019.00932. eCollection 2019.
2
T1-2 glottic cancer treated with radiotherapy and/or surgery.采用放疗和/或手术治疗的T1-2期声门癌。
Strahlenther Onkol. 2017 Dec;193(12):995-1004. doi: 10.1007/s00066-017-1139-4. Epub 2017 May 4.
3
Definitive radiation therapy for early glottic cancer: experience of two fractionation schedules.
早期声门型癌症的根治性放射治疗:两种分割方案的经验。
Clin Exp Otorhinolaryngol. 2012 Jun;5(2):94-100. doi: 10.3342/ceo.2012.5.2.94. Epub 2012 Jun 12.
4
Cystatin C - a fast and reliable biomarker for glomerular filtration rate in head and neck cancer patients.胱抑素 C - 头颈部癌症患者肾小球滤过率的快速可靠生物标志物。
Strahlenther Onkol. 2011 Mar;187(3):191-201. doi: 10.1007/s00066-010-2203-5. Epub 2011 Feb 24.
5
Multidisciplinary approach in the treatment of T1 glottic cancer. The role of patient preference in a homogenous patient population.多学科方法治疗 T1 声门型喉癌。在同质患者人群中患者偏好的作用。
Strahlenther Onkol. 2010 Nov;186(11):607-13. doi: 10.1007/s00066-010-2142-1. Epub 2010 Nov 8.
6
Intraoperative radiotherapy (IORT) with low-energy photons as a boost in patients with early-stage oral cancer with the indications for postoperative radiotherapy : treatment feasibility and preliminary results.术中放疗(IORT)联合低能光子作为术后放疗指征的早期口腔癌患者的辅助治疗:治疗可行性和初步结果。
Strahlenther Onkol. 2010 Sep;186(9):496-501. doi: 10.1007/s00066-010-2117-2. Epub 2010 Aug 30.